Cyclic progestin therapy for the management of mastopathy and mastodynia

@article{Winkler2001CyclicPT,
  title={Cyclic progestin therapy for the management of mastopathy and mastodynia},
  author={U. Winkler and A. Schindler and U. Brinkmann and C. Ebert and C. Oberhoff},
  journal={Gynecological Endocrinology},
  year={2001},
  volume={15},
  pages={37 - 43}
}
The management of benign diseases of the breast aims to halt the progression of fibrocystic transformation and to eliminate the symptoms of pain and breast tenderness. Progestins can be used for this purpose. In a controlled, randomized, double-blind, parallel-group study we treated 31 women with mastopathy/mastodynia with the progestins medrogestone (10 mg/day) or dydrogesterone (10 mg/day) from day 14 to day 25 for six cycles. Before, during and at the end of therapy the following parameters… Expand
Dienogest and the breast
Evaluation and management of breast pain.
Dydrogesterone and other progestins in benign breast disease: an overview
  • A. Schindler
  • Medicine
  • Archives of Gynecology and Obstetrics
  • 2010
Molecular screening of Chinese medicinal plants for progestogenic and anti-progestogenic activity
Dolori al seno
...
1
2
...

References

SHOWING 1-10 OF 30 REFERENCES
Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
  • H. Vorherr
  • Medicine
  • American journal of obstetrics and gynecology
  • 1986
Treatment of premenstrual syndrome. A double-blind trial of dydrogesterone.
Medical management of mammary dysplasia.
...
1
2
3
...